LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial

S. Senan, David R. Spigel, Byoung Chul Cho, К. К. Лактионов, Yoshitaka Zenke, Ki Hyeong Lee, Q. Wang, A.F. Navarro Mendivil, E.L. Buchmeier, Sema Sezgin Göksu, A. Badzio, A. SHI, Davey B. Daniel, Milada Zemanová, P. Iyengar, Luis Paz‐Ares, Leah Szadkowski, P. Chugh, W.C.V. Lai, Y. Cheng